Does Aetna Medicare Advantage Cover Wegovy? Medicare Advantage Coverage Guide 2026
Seniors on Medicare Advantage on Aetna Medicare (administered by Aetna/CVS Health) frequently want to know whether the formulary covers Wegovy (semaglutide 2.4mg). In brief: coverage is determined by several plan-specific factors.
Aetna Medicare Advantage’s Formulary Position on Wegovy
Aetna Medicare maintains a Part D formulary that categorizes medications into cost-sharing tiers. Currently, Wegovy is typically classified as Tier 5 (Specialty) on most Aetna Medicare Advantage plan options.
Cost implications:
- Cost-sharing: $100–$300+ based on your specific plan design
- Prior authorization: Yes — your doctor must submit
- Quantity limits: Often enforced — limited to FDA-recommended dosing
- Step therapy: Might need failed trial of first-line therapies first
In the donut hole phase, enrollees pay a larger share until catastrophic coverage kicks in.
Coverage for Different Indications
For chronic weight management (FDA-approved):
- Aetna Medicare Advantage typically will authorize Wegovy for on-label use
- Required evidence: HbA1c levels, prior medication history
- Coverage is more consistent when used on-label
For weight loss (if seeking obesity coverage):
- Traditional Medicare does not cover anti-obesity medications under Part D
- That said: 2025 policy changes broadened formulary inclusion rules for GLP-1s prescribed for obesity
- Aetna Medicare Advantage may offer additional drug benefits that include weight management medications — call Aetna/CVS Health member services
Estimated Costs With Aetna Medicare Advantage
Understanding your actual cost for Wegovy on Aetna Medicare Advantage requires knowing which Part D coverage phase you’re in.
| Coverage Phase | Approximate Cost |
|---|---|
| Initial Deductible ($545 in 2026) | You pay everything: $1,300–$1,500/month |
| Initial Coverage | 25-33% coinsurance |
| Coverage Gap (Donut Hole) | Significant coinsurance |
| Catastrophic Coverage | Minimal cost |
The IRA’s $2,000 annual cap, out-of-pocket Part D spending is capped at $2,000/year — providing substantial relief to anyone taking Wegovy.
Tips for Getting Approved
- Request a formulary exception — When cost is prohibitive, your doctor can submit a tier reduction or formulary exception with medical necessity evidence
- Apply for patient assistance — Novo Nordisk runs patient assistance programs for eligible Medicare enrollees (note: savings cards typically don’t work with government plans)
- Switch plans if needed — AEP (Oct 15–Dec 7) is your chance to switch to a plan with better Wegovy coverage
- Apply for Extra Help/LIS — If income-eligible can receive Extra Help (Low-Income Subsidy) that significantly reduce out-of-pocket expenses